Laguitao, Jeannevive M.

HRN: 04-59-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
CEFUROXIME 1.5GM (VIAL)
08/16/2025
08/17/2025
IVTT
1.5gram
1hr PTOR
For TAHBSO
Checking Initial Appropriateness 
08/16/2025
CEFUROXIME 1.5GM (VIAL)
08/16/2025
08/17/2025
IV
1.5gram
Post OR
S/P TAHRS
Checking Initial Appropriateness 
08/16/2025
CEFUROXIME 500MG (TAB)
08/16/2025
08/23/2025
PO
1 Tab
Q12h
S/P TAHRS
Checking Initial Appropriateness 
08/19/2025
CEFUROXIME 500MG (TAB)
08/19/2025
08/26/2025
PO
500mg
BID
SP TAHRS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: